AI CAPITAL INTELLIGENCE

柏垠生物 · Multiple rounds · Lower bound: CNY 200,000,000 · 2026-10-22

Financing facts, at a glance

柏垠生物: financing disclosed on 2026-10-22, Multiple rounds, Lower bound: CNY 200,000,000. Named investors: 沃博联广药基金, 欧莱雅BOLD基金, 富华资本, 基石资本, 星博生辉, 君科丹木, 广新基金. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.

Original source 1 · Original source 2 · Original source 3 · Original source 4

柏垠生物 is recorded in the Industry AI / Drug discovery & life sciences segment. The disclosed financing is Multiple rounds, with an amount of Lower bound: CNY 200,000,000. Named investors include 沃博联广药基金, 欧莱雅BOLD基金, 富华资本, 基石资本, 星博生辉, 君科丹木, 广新基金.

Disclosed company name
深圳柏垠生物科技有限公司
Disclosure date
2026-10-22
Round
Multiple rounds
Financing amount
Lower bound: CNY 200,000,000
Market coverage
China
Sector
Industry AI / Drug discovery & life sciences
Product form
AI professional services

Disclosed investors

沃博联广药基金, 欧莱雅BOLD基金, 富华资本, 基石资本, 星博生辉, 君科丹木, 广新基金

Original sources

  1. 创新AI原生生物材料企业柏垠生物完成超2亿元A轮系列融资

    news.pedaily.cn · Original publication date not recorded

  2. 【首发】获多家世界500强产业资本支持,柏垠生物完成超2亿元A轮系列融资医药新闻-ByDrug-一站式医药资源共享中心-医药魔方

    bydrug.pharmcube.com · Original publication date not recorded

  3. 柏垠生物完成超2亿元A轮系列融资

    tech.sina.cn · Original publication date not recorded

  4. 2026Q2 中国院内外药品市场销售分析报告_医药魔方

    bydrug.pharmcube.com · Original publication date not recorded

Record reviewed as of . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.

Company funding history

Explore this sector

富华资本 (Chinese)

基石资本 (Chinese)

All funding records

Citation and coverage

Compiled and linked by Wavesight AI. Financing facts are attributable to the original disclosure sources; coverage is our recorded sample, not the whole market.

Wavesight AI|柏垠生物 · Multiple rounds · Lower bound: CNY 200,000,000 · 2026-10-22。柏垠生物: financing disclosed on 2026-10-22, Multiple rounds, Lower bound: CNY 200,000,000. Named investors: 沃博联广药基金, 欧莱雅BOLD基金, 富华资本, 基石资本, 星博生辉, 君科丹木, 广新基金. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment. Compiled and linked by Wavesight AI. Financing facts are attributable to the original disclosure sources; coverage is our recorded sample, not the whole market. https://www.zkdlj.vip/en/funding/FI-ead03f18fb1f8e46/#conclusion-overview

Link to conclusion